MARÍA DEL CARMEN
MORENO RUIZ
Profesora asociada de Ciencias de la Salud
![Foto de MARÍA DEL CARMEN](/img/uploaded/063665A1721303F53C833D034725DD8D.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (9)
2022
-
Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale
European Child and Adolescent Psychiatry, Vol. 31, Núm. 11, pp. 1715-1728
2021
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2020
-
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis
Journal of Affective Disorders, Vol. 275, pp. 48-57
2018
-
Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis
European Child and Adolescent Psychiatry, Vol. 27, Núm. 1, pp. 113-126
-
The complex association between the antioxidant defense system and clinical status in early psychosis
PLoS ONE, Vol. 13, Núm. 4
2016
-
Involvement of NRN1 gene in schizophrenia-spectrum and bipolar disorders and its impact on age at onset and cognitive functioning
World Journal of Biological Psychiatry, Vol. 17, Núm. 2, pp. 129-139
2015
-
Predictors of functional and clinical outcome in early-onset first-episode psychosis: The child and adolescent first episode of psychosis (CAFEPS) study
Journal of Clinical Psychiatry, Vol. 76, Núm. 11, pp. e1441-e1448
2014
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
2013
-
Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: Discontinuation and tolerability
Journal of Clinical Psychopharmacology, Vol. 33, Núm. 4, pp. 463-471